Korro to Participate in Upcoming Investor Conferences
Korro Bio (NASDAQ: KRRO) has announced its management team's participation in three major upcoming healthcare investor conferences in May and June 2025. CEO and President Ram Aiyar, Ph.D., will lead a fireside chat at the RBC Capital Markets Global Healthcare Conference on May 21. Both Dr. Aiyar and Chief Medical Officer Kemi Olugemo, M.D., FAAN, will present at the Jefferies Global Healthcare Conference on June 4 and the Goldman Sachs 46th Annual Global Healthcare Conference on June 9.
The RBC fireside chat will be available via webcast on Korro's website, with a replay accessible for 30 days following the event.
Korro Bio (NASDAQ: KRRO) ha annunciato la partecipazione del suo team dirigenziale a tre importanti conferenze per investitori nel settore sanitario previste per maggio e giugno 2025. Il CEO e Presidente Ram Aiyar, Ph.D., condurrà una tavola rotonda informale durante la RBC Capital Markets Global Healthcare Conference il 21 maggio. Sia il Dr. Aiyar che la Chief Medical Officer Kemi Olugemo, M.D., FAAN, presenteranno alla Jefferies Global Healthcare Conference il 4 giugno e alla 46ª Annuale Goldman Sachs Global Healthcare Conference il 9 giugno.
La tavola rotonda della RBC sarà disponibile in webcast sul sito di Korro, con la possibilità di rivederla per 30 giorni dopo l'evento.
Korro Bio (NASDAQ: KRRO) ha anunciado la participación de su equipo directivo en tres importantes conferencias para inversores en el sector sanitario que se celebrarán en mayo y junio de 2025. El CEO y Presidente Ram Aiyar, Ph.D., dirigirá una charla informal en la RBC Capital Markets Global Healthcare Conference el 21 de mayo. Tanto el Dr. Aiyar como la Directora Médica Kemi Olugemo, M.D., FAAN, presentarán en la Jefferies Global Healthcare Conference el 4 de junio y en la 46ª Conferencia Anual Global de Salud de Goldman Sachs el 9 de junio.
La charla informal de RBC estará disponible por webcast en la página web de Korro, con una repetición accesible durante 30 días después del evento.
Korro Bio (NASDAQ: KRRO)는 2025년 5월과 6월에 예정된 세 차례 주요 헬스케어 투자자 컨퍼런스에 경영진이 참여할 것이라고 발표했습니다. CEO 겸 사장 Ram Aiyar 박사가 5월 21일 RBC Capital Markets 글로벌 헬스케어 컨퍼런스에서 파이어사이드 채팅을 진행할 예정입니다. Aiyar 박사와 최고 의료 책임자 Kemi Olugemo 박사, FAAN는 6월 4일 Jefferies 글로벌 헬스케어 컨퍼런스와 6월 9일 Goldman Sachs 제46회 연례 글로벌 헬스케어 컨퍼런스에서 발표할 예정입니다.
RBC 파이어사이드 채팅은 Korro 웹사이트에서 웹캐스트로 제공되며, 행사 후 30일 동안 다시보기 가능합니다.
Korro Bio (NASDAQ : KRRO) a annoncé la participation de son équipe de direction à trois grandes conférences d'investisseurs dans le secteur de la santé prévues en mai et juin 2025. Le PDG et président Ram Aiyar, Ph.D., animera une discussion informelle lors de la RBC Capital Markets Global Healthcare Conference le 21 mai. Le Dr Aiyar et la directrice médicale Kemi Olugemo, M.D., FAAN, présenteront lors de la Jefferies Global Healthcare Conference le 4 juin et lors de la 46e conférence annuelle mondiale sur la santé de Goldman Sachs le 9 juin.
La discussion informelle de RBC sera accessible en webcast sur le site de Korro, avec une rediffusion disponible pendant 30 jours après l'événement.
Korro Bio (NASDAQ: KRRO) hat die Teilnahme seines Managementteams an drei wichtigen bevorstehenden Gesundheitsinvestorenkonferenzen im Mai und Juni 2025 angekündigt. CEO und Präsident Ram Aiyar, Ph.D., wird am 21. Mai ein Fireside-Chat auf der RBC Capital Markets Global Healthcare Conference leiten. Sowohl Dr. Aiyar als auch Chief Medical Officer Kemi Olugemo, M.D., FAAN, werden am 4. Juni auf der Jefferies Global Healthcare Conference und am 9. Juni auf der 46. jährlichen Goldman Sachs Global Healthcare Conference präsentieren.
Der Fireside-Chat der RBC wird über einen Webcast auf der Korro-Website verfügbar sein, mit einer Wiedergabe, die 30 Tage nach der Veranstaltung abrufbar ist.
- None.
- None.
CAMBRIDGE, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that members of management will participate in the following upcoming investor conferences:
2025 RBC Capital Markets Global Healthcare Conference
Ram Aiyar, Ph.D., Chief Executive Officer and President, will participate in a fireside chat on Wednesday, May 21, 2025, at 2:35 p.m. ET.
Jefferies Global Healthcare Conference
Dr. Aiyar and Kemi Olugemo, M.D., FAAN, Chief Medical Officer, will present on Wednesday, June 4, 2025, at 9:55 a.m. ET.
Goldman Sachs 46th Annual Global Healthcare Conference
Dr. Aiyar and Dr. Olugemo, will present on Monday, June 9, 2025, at 4:00 p.m. ET.
A live webcast of the RBC fireside chat can be accessed on the “Events & Presentations” page in the Investor section of Korro’s website at www.korrobio.com. Following the fireside chat, a replay of the event will be available for 30 days.
About Korro
Korro is a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent diseases. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process, enabling a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro is based in Cambridge, Massachusetts. For more information, visit korrobio.com.
Korro intends to use its Investor Relations website, LinkedIn, and X (Twitter) as means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation FD. Accordingly, investors should monitor Korro’s Investor Relations website and follow @KorroBio on LinkedIn, and X (Twitter), in addition to following Korro’s press releases, SEC filings, public conference calls, presentations, and webcasts.
Korro Bio Contact Information
Investors
IR@korrobio.com
Media
Glenn Silver
FINN Partners
Glenn.silver@finnpartners.com
This press release was published by a CLEAR® Verified individual.
FAQ
When is Korro Bio (KRRO) presenting at the RBC Capital Markets Healthcare Conference 2025?
Who will represent Korro Bio (KRRO) at the upcoming investor conferences?
How can investors access Korro Bio's (KRRO) presentation at the RBC Healthcare Conference?
What time is Korro Bio's (KRRO) presentation at the Goldman Sachs Healthcare Conference?
